147 related articles for article (PubMed ID: 12696108)
1. Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infection.
MacQuillan GC; Mamotte C; Reed WD; Jeffrey GP; Allan JE
J Med Virol; 2003 Jun; 70(2):219-27. PubMed ID: 12696108
[TBL] [Abstract][Full Text] [Related]
2. IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy.
Abe H; Hayes CN; Ochi H; Maekawa T; Tsuge M; Miki D; Mitsui F; Hiraga N; Imamura M; Takahashi S; Kubo M; Nakamura Y; Chayama K
J Hepatol; 2011 Jun; 54(6):1094-101. PubMed ID: 21145800
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection.
MacQuillan GC; de Boer WB; Platten MA; McCaul KA; Reed WD; Jeffrey GP; Allan JE
J Med Virol; 2002 Oct; 68(2):197-205. PubMed ID: 12210408
[TBL] [Abstract][Full Text] [Related]
4. Intrahepatic mRNA levels of type I interferon receptor and interferon-stimulated genes in genotype 1b chronic hepatitis C. Association between IFNAR1 mRNA level and sustained response to interferon therapy.
Taniguchi H; Iwasaki Y; Takahashi A; Shimomura H; Moriya A; Yu PC; Umeoka F; Fujioka S; Koide N; Shiratori Y
Intervirology; 2007; 50(1):32-9. PubMed ID: 17164555
[TBL] [Abstract][Full Text] [Related]
5. Interferon-stimulated gene expression in black and white hepatitis C patients during peginterferon alfa-2a combination therapy.
Luo S; Cassidy W; Jeffers L; Reddy KR; Bruno C; Howell CD
Clin Gastroenterol Hepatol; 2005 May; 3(5):499-506. PubMed ID: 15880320
[TBL] [Abstract][Full Text] [Related]
6. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
Murakawa M; Asahina Y; Kawai-Kitahata F; Nakagawa M; Nitta S; Otani S; Nagata H; Kaneko S; Asano Y; Tsunoda T; Miyoshi M; Itsui Y; Azuma S; Kakinuma S; Tanaka Y; Iijima S; Tsuchiya K; Izumi N; Tohda S; Watanabe M
J Med Virol; 2017 Jul; 89(7):1241-1247. PubMed ID: 28036111
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.
Knapp S; Yee LJ; Frodsham AJ; Hennig BJ; Hellier S; Zhang L; Wright M; Chiaramonte M; Graves M; Thomas HC; Hill AV; Thursz MR
Genes Immun; 2003 Sep; 4(6):411-9. PubMed ID: 12944978
[TBL] [Abstract][Full Text] [Related]
8. IL-29 and IFN-α regulate the expression of MxA, 2',5'-OAS and PKR genes in association with the activation of Raf-MEK-ERK and PI3K-AKT signal pathways in HepG2.2.15 cells.
Chai Y; Huang HL; Hu DJ; Luo X; Tao QS; Zhang XL; Zhang SQ
Mol Biol Rep; 2011 Jan; 38(1):139-43. PubMed ID: 20309637
[TBL] [Abstract][Full Text] [Related]
9. Anti-viral actions and viral dynamics in the early phase of three different regimens of interferon treatment for chronic hepatitis C: differences between the twice-daily administration of interferon-beta treatment and the combination therapy with interferon-alpha plus ribavirin.
Nakajima H; Shimomura H; Iwasaki Y; Ikeda F; Umeoka F; Chengyu P; Taniguchi H; Ohnishi Y; Takagi SJ; Fujioka S; Shiratori Y
Acta Med Okayama; 2003 Oct; 57(5):217-25. PubMed ID: 14679399
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes.
de Lucas S; Bartolome J; Carreno V
J Infect Dis; 2005 Jan; 191(1):93-9. PubMed ID: 15593009
[TBL] [Abstract][Full Text] [Related]
11. PKR gene expression and response to pegylated interferon plus ribavirin therapy in chronic hepatitis C.
Gerotto M; Dal Pero F; Bortoletto G; Realdon S; Ferrari A; Boccato S; Alberti A
Antivir Ther; 2004 Oct; 9(5):763-70. PubMed ID: 15535414
[TBL] [Abstract][Full Text] [Related]
12. 2'-,5'-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C.
Kim KI; Kim SR; Sasase N; Taniguchi M; Harada S; Kinoshita K; Kim SH; Akimoto Y; Shikata M; Kimura N; Izawa S; Ohtani A; Nakao K; Motojima M; Kinoshita M; Hirai M; Ohzu M; Hirooka T; Nabeshima S; Ishii F; Tanaka K; Hotta H
J Clin Pharm Ther; 2006 Oct; 31(5):441-6. PubMed ID: 16958821
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin.
Asahina Y; Izumi N; Umeda N; Hosokawa T; Ueda K; Doi F; Tsuchiya K; Nakanishi H; Matsunaga K; Kitamura T; Kurosaki M; Uchihara M; Higaki M; Miyake S
J Viral Hepat; 2007 Jun; 14(6):396-403. PubMed ID: 17501760
[TBL] [Abstract][Full Text] [Related]
14. SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29.
Brand S; Zitzmann K; Dambacher J; Beigel F; Olszak T; Vlotides G; Eichhorst ST; Göke B; Diepolder H; Auernhammer CJ
Biochem Biophys Res Commun; 2005 Jun; 331(2):543-8. PubMed ID: 15850793
[TBL] [Abstract][Full Text] [Related]
15. Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.
Abbate I; Romano M; Longo R; Cappiello G; Lo Iacono O; Di Marco V; Paparella C; Spano A; Capobianchi MR
J Med Virol; 2003 Aug; 70(4):581-7. PubMed ID: 12794720
[TBL] [Abstract][Full Text] [Related]
16. Expression of interferon alfa signaling components in human alcoholic liver disease.
Nguyen VA; Gao B
Hepatology; 2002 Feb; 35(2):425-32. PubMed ID: 11826419
[TBL] [Abstract][Full Text] [Related]
17. Impaired antiviral response in human hepatoma cells.
Keskinen P; Nyqvist M; Sareneva T; Pirhonen J; Melén K; Julkunen I
Virology; 1999 Oct; 263(2):364-75. PubMed ID: 10544109
[TBL] [Abstract][Full Text] [Related]
18. Hepatic interferon receptor mRNA expression: clinical relevance and its relationship with effectiveness of interferon plus ribavirin therapy in patients with genotype 1b hepatitis C virus infection.
Lee CM; Kee KM; Hung CH; Eng HL; Chang CH; Huang CM; Wang JH; Hu TH; Lu SN; Changchien CS; Chen WJ
Antivir Ther; 2006; 11(1):17-23. PubMed ID: 16518956
[TBL] [Abstract][Full Text] [Related]
19. Novel functions of proteins encoded by viral stress-inducible genes.
Sarkar SN; Sen GC
Pharmacol Ther; 2004 Sep; 103(3):245-59. PubMed ID: 15464592
[TBL] [Abstract][Full Text] [Related]
20. Influence of GBV-C infection on the endogenous activation of the IFN system in HIV-1 co-infected patients.
Capobianchi MR; Lalle E; Martini F; Poccia F; D'Offizi G; Antonucci G; Abbate I; Dianzani F
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):3-8. PubMed ID: 16914092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
